天目药业: 杭州天目山药业股份有限公司信息披露管理办法（2025年8月修订）

Core Viewpoint - The document outlines the information disclosure management system of Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd, emphasizing the importance of timely, accurate, and complete information disclosure to protect the rights of the company and its investors [1][2]. Group 1: General Principles - The information disclosure obligations must be fulfilled timely and should be true, accurate, complete, and fair, avoiding any false records or misleading statements [2][3]. - The system applies to various personnel including the board of directors, senior management, and major shareholders [2][3]. - The company must ensure that all disclosed information is made available to all investors simultaneously, without any selective disclosure [4][5]. Group 2: Disclosure Content - The company is required to disclose periodic reports, including annual, semi-annual, and quarterly reports, as well as other significant documents like prospectuses and acquisition reports [6][7]. - Annual reports must be disclosed within four months after the fiscal year-end, while semi-annual reports should be disclosed within two months after the first half of the fiscal year [7][8]. - The content of the annual report includes basic company information, major financial data, stock and bond issuance details, and significant events affecting the company [8][9]. Group 3: Responsibilities and Management - The board of directors is responsible for overseeing the information disclosure process, with the chairman being the primary responsible person [17][18]. - The board secretary plays a crucial role in coordinating the information disclosure activities and ensuring compliance with relevant regulations [17][18]. - All departments and subsidiaries must report significant information to the board secretary promptly to ensure timely disclosure [21][22]. Group 4: Compliance and Training - The company must provide training on information disclosure responsibilities to relevant personnel to ensure compliance with regulations [25][26]. - Any violations of the disclosure obligations may lead to administrative and economic penalties for responsible individuals [26][27]. - The company must maintain communication with regulatory bodies and ensure that all disclosures are in line with legal requirements [25][28].